Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization

Tattersall, 1974, Mild familial diabetes with dominant inheritance, Quarterly Journal of Medicine, 43, 339 O'Rahilly, 1987, Type II diabetes of early onset: a distinct clinical and genetic syndrome?, British Medical Journal, 294, 923, 10.1136/bmj.294.6577.923 1999, Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus Froguel, 1992, Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus, Nature, 356, 162, 10.1038/356162a0 Hattersley, 1992, Linkage of type 2 diabetes to the glucokinase gene, Lancet, 339, 1307, 10.1016/0140-6736(92)91958-B Bell, 1991, Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q, Proceedings of the National Academy of Sciences of the USA, 88, 1484, 10.1073/pnas.88.4.1484 Vaxillaire, 1995, A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q, Nature Genetics, 9, 418, 10.1038/ng0495-418 Yamagata, 1996, Mutations in the hepatic nuclear factor 1 alpha gene in maturity-onset diabetes of the young (MODY3), Nature, 384, 455, 10.1038/384455a0 Yamagata, 1996, Mutations in the hepatocyte nuclear factor 4 alpha gene in maturity-onset diabetes of the young (MODY1), Nature, 384, 458, 10.1038/384458a0 Horikawa, 1997, Mutation in hepatocyte nuclear factor-1b gene (TCF2) associated with MODY, Nature Genetics, 17, 384, 10.1038/ng1297-384 Stoffers, 1997, Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence, Nature Genetics, 15, 106, 10.1038/ng0197-106 Stoffers, 1997, Early-onset type-II diabetes mellitus (MODY4) linked to IPF1, Nature Genetics, 17, 138, 10.1038/ng1097-138 Meglasson, 1986, Pancreatic islet glucose metabolism and regulation of insulin secretion, Diabetes and Metabolism Reviews, 2, 163, 10.1002/dmr.5610020301 Hattersley, 1998, Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity, Diabetic Medicine, 15, 15, 10.1002/(SICI)1096-9136(199801)15:1<15::AID-DIA562>3.0.CO;2-M Glaser, 1998, Familial hyperinsulinism caused by an activating glucokinase mutation, New England Journal of Medicine, 338, 226, 10.1056/NEJM199801223380404 Pearson, 2001, Beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor 1-alpha and glucokinase mutations, Diabetes, 50, S101, 10.2337/diabetes.50.2007.S101 Page, 1995, Clinical characteristics of subjects with a missense mutation in glucokinase, Diabetic Medicine, 12, 209, 10.1111/j.1464-5491.1995.tb00460.x Byrne, 1994, Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations, Journal of Clinical Investigation, 93, 1120, 10.1172/JCI117064 Velho, 1992, Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young, Lancet, 340, 444, 10.1016/0140-6736(92)91768-4 O'Rahilly, 1994, Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophesy?, Lancet, 344, 585, 10.1016/S0140-6736(94)91969-0 Velho, 1996, Impaired hepatic glycogen-synthesis in glucokinase-deficient (MODY2) subjects, Journal of Clinical Investigation, 98, 1755, 10.1172/JCI118974 Velho, 1997, Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families, Diabetologia, 40, 217, 10.1007/s001250050666 Saker, 1996, High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population, Diabetologia, 39, 1325, 10.1007/s001250050577 Hattersley, 1998, Mutations in the glucokinase gene of the fetus result in reduced birth weight, Nature Genetics, 19, 268, 10.1038/953 Ellard, 2000, A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria, Diabetologia, 43, 250, 10.1007/s001250050038 Njolstad, 2001, Permanent neonatal diabetes mellitus due to glucokinase deficiency: an inborn error of the glucose/insulin signaling pathway, New England Journal of Medicine, 344, 1588, 10.1056/NEJM200105243442104 Ellard, 2000, HNF-1alpha mutations in MODY, Human Mutation, 16, 377, 10.1002/1098-1004(200011)16:5<377::AID-HUMU1>3.0.CO;2-2 Frayling, 1997, A rapid screening method for HNF- 1 alpha; prevalence in MODY and late-onset non-insulin dependent diabetes, Human Genetics, 101, 351, 10.1007/s004390050640 Appleton, 1997, Clinical characteristics of the HNF1α (MODY3) and glucokinase mutations, Diabetologia, 40, A161 Shepherd, 2001, Genetic testing in maturity onset diabetes of the young (MODY): a new challenge for the diabetic clinic, Practical Diabetes, 18, 16, 10.1002/pdi.108 Lehto, 1997, Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect, Journal of Clinical Investigation, 99, 582, 10.1172/JCI119199 Byrne, 1996, Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on Chromosome 12, Diabetes, 45, 1503, 10.2337/diab.45.11.1503 Pearson, 2000, Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor 1 alpha gene mutations: evidence for pharmacogenetics in diabetes, Diabetic Medicine, 17, 543, 10.1046/j.1464-5491.2000.00305.x Ellard, 2000, Proposed mechanism for a novel insertion/deletion frameshift mutation (1414G415ATCG-CCA) in the HNF-1α gene which causes MODY, Human Mutation, 16, 273, 10.1002/1098-1004(200009)16:3<273::AID-HUMU18>3.0.CO;2-Z Menzel, 1998, A low renal threshold for glucose in diabetic patients with a mutation in HNF-1 alpha gene, Diabetic Medicine, 15, 816, 10.1002/(SICI)1096-9136(199810)15:10<816::AID-DIA714>3.0.CO;2-P Pontoglio, 2000, HNF1 alpha controls renal glucose reabsorption in mouse and man, EMBO Reports, 1, 359, 10.1093/embo-reports/kvd071 Cox, 1992, Mapping diabetes-susceptibility genes. Lessons learned from search for DNA marker for maturity-onset diabetes of the young, Diabetes, 41, 401, 10.2337/diab.41.4.401 Hani, 1998, A missense mutation in HNF-4 alpha, resulting in a reduced transactivation activity, in human late-onset non- insulin-dependent diabetes mellitus, Journal of Clinical Investigation, 101, 521, 10.1172/JCI1403 Lehto, 1999, Mutation in the HNF-4 alpha gene affects insulin secretion and triglyceride metabolism, Diabetes, 48, 423, 10.2337/diabetes.48.2.423 Beards, 1998, Mutations in HNF-1 beta are not a common cause of maturity-onset diabetes of the young in the U.K, Diabetes, 47, 1152, 10.2337/diabetes.47.7.1152 Nishigori, 1998, Frameshift mutation, A263fsinsGG, in the HNF-1 beta gene associated with diabetes and renal dysfunction, Diabetes, 47, 1354 Bingham, 2000, Abnormal nephron development associated with a frameshift mutation in the transcription factor HNF-1 beta, Kidney International, 57, 898, 10.1046/j.1523-1755.2000.057003898.x Lindner, 1999, A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of HNF-1 beta, Human Molecular Genetics, 8, 2001, 10.1093/hmg/8.11.2001 Bingham, 2001, Mutations in the HNF1-beta gene are associated with familial hypoplastic glomerulocystic kidney disease, American Journal of Human Genetics, 68, 219, 10.1086/316945 Edlund, 1998, Transcribing Pancreas, Diabetes, 47, 1817, 10.2337/diabetes.47.12.1817 Chevre, 1998, Insulin promoter factor 1 gene is not a major cause of maturity-onset diabetes of the young in French Caucasians, Diabetes, 47, 843, 10.2337/diabetes.47.5.843 Macfarlane, 1999, Missense mutations in the IPF-1 gene predispose to type 2 diabetes, Journal of Clinical Investigation, 104, R33, 10.1172/JCI7449 Hara, 1998, Mutations in the coding region of the IPF 1 gene are not a common cause of maturity-onset diabetes of the young in Japanese subjects, Diabetes, 47, 845, 10.2337/diabetes.47.5.845 Hani, 1999, Defective mutations in the IPF-1 gene in late-onset type 2 diabetes mellitus, Journal of Clinical Investigation, 104, R41, 10.1172/JCI7469 Weng, 2001, Functional consequences of mutations in the MODY4 gene (IPF-1) and co-existence with MODY3 mutation, Diabetologia, 44, 249, 10.1007/s001250051608 Chevre, 1998, Mutation screening in 18 Caucasian families suggests the existence of other MODY genes, Diabetologia, 41, 1017, 10.1007/s001250051025 Gragnoli, 1997, Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4 alpha binding site in the promoter of the hepatocyte nuclear fatcor-1 alpha gene, Diabetes, 46, 1648, 10.2337/diacare.46.10.1648 Malecki, 1999, Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus, Nature Genetics, 23, 323, 10.1038/15500